Testing aimed at restoring vaginal health
Our Aerobic Vaginitis Infection Panel (AVIP™) provides valuable insight to help you get the care you need for lasting relief and restored vaginal health.
When it comes to your vaginal health, you want a full picture.
Many vaginal health issues go undiagnosed or misdiagnosed due to overlapping symptoms. Aerobic vaginitis, a common yet often overlooked condition, requires identification for effective treatment.1 Without the full picture, treatment can fall short.
Molecular and culture testing together from the start.
Our testing is designed to identify the most common pathogens. All samples are cultured and tested against a panel of antibiotics.
Collect and send your vaginal swab to CirrusDx.
Your sample is analyzed to determine if bacteria and/or yeast are present and which treatment(s) may be most effective.
Your healthcare provider gets actionable results to guide treatment decisions.
Aerobic vaginitis (AV) is an infection caused by an overgrowth of aerobic bacteria like E. coli and Enterococcus faecalis, leading to vaginal inflammation and discomfort. Diagnosing AV is crucial to restoring the healthy balance of vaginal bacteria, promoting overall vaginal health, and helping to guide a treatment plan that may reduce the likelihood of ineffective therapies.
Aerobic vaginitis (AV) is a condition where there is a shift in the normal vaginal microbiome, with a reduction in protective Lactobacillus species and an overgrowth of aerobic bacteria such as E. coli and Enterococcus. This differs from bacterial vaginosis (BV), which involves overgrowth of anaerobic bacteria. In AV, this imbalance is more often associated with signs of irritation or inflammation.2 Changes in vaginal bacterial balance have also been associated with an increased risk of urinary tract infections (UTIs), highlighting the importance of clear identification and appropriate clinical management.3
Your specimen is processed using two complementary approaches. We begin with molecular testing to detect and characterize potential pathogens. In parallel, the sample is directly cultured using modernized microbiology methods to grow and confirm organisms that may be present.
By evaluating the same sample directly with different methods, we’re able to generate a more detailed microbiological profile. This combined approach gives your healthcare provider the information to support more informed decisions about your care.
Integrated approach
Our approach is guided by expertise in pathogen identification and antibiotic susceptibility direct from your cultured sample. The goal is to provide you and your provider with a comprehensive picture of what’s happening.
Clinical expertise & support
Our focus is on providing clear communication and accessible clinical support whenever you need guidance or have questions about a result.
Concise reporting
Our reports are designed to present findings in an accessible format that helps providers and patients better understand results and support next steps in care.
Partner with CirrusDx
Choosing CirrusDx means partnering with a team focused on quality and compassionate care. We’re here to support you and your family with the information and guidance needed to move forward with confidence.
Reach out today
Learn how CirrusDx can support your vaginal health and provide the insight and clinical support you deserve.
1. Sonthalia S, Aerobic Vaginitis? A Common but Underdiagnosed Cause of Recurrent Vaginal Discharge of Dysbiotic Origin? Are We Dealing with a Cryptic STI? Immunology Case Reports. 2020; Vol.4 No.3.
2. Donders et al. (foundational AV definition + inflammation + aerobic shift) Donders GG. Definition and classification of abnormal vaginal flora. American Journal of Obstetrics and Gynecology. 2002;186(4):S26–S29.
3. Brubaker L, Wolfe AJ. The female urinary microbiota, urinary health and common urinary disorders. Ann Transl Med. 2017;5(2):34.
We use cookies to personalize content and ads, provide social share features, and analyze our traffic. To deliver personalized ads, we share information about your use of our site with our advertising and analytics partners. View our cookie policy here to learn how to manage your cookie settings. Privacy Policy.